We established that endogenous mutp53 in human cancers suffers from a profound lack of ubiquitination—the root cause of its degradation defect—despite detectable (albeit lower) Mdm2 levels and normal Mdm2 interactions. The gene discussed is MDM2; the disease is cancer.